TY  - JOUR
AU  - Giordano, G.
AU  - Remo, A.
AU  - Porras Gallo, María Almudena
AU  - Pancione, M.
PY  - 2019
DO  - 10.3390/cancers11081089
SN  - 2072-6694
UR  - https://hdl.handle.net/20.500.14352/12658
T2  - Cancers
AB  - Targeting the epidermal growth factor receptor (EGFR) either alone or in combination with chemotherapy in patients with RAS wild type metastatic colorectal cancer (mCRC) has revolutionized the treatment of CRC, but with less results than initially...
LA  - eng
M2  - 1089
PB  - MDPI
KW  - Colorectal cancer
KW  - EGFR
KW  - Resistance
KW  - Targeted therapies
KW  - Immune microenvironment
TI  - Immune Resistance and EGFR Antagonists in Colorectal Cancer
TY  - journal article
VL  - 11
ER  -